Biomab Injection

Get a Price/Quote

Product Details:

Dosage Form Injection
Salt Composition Nimotuzumab (50mg) per vial
Indication Head and neck cancer, Glioma, Non-small cell lung cancer, Esophageal cancer, Breast cancer
Enzyme Types Monoclonal antibody (IgG1 class)
Feature Humanized monoclonal antibody, Highly selective anti-EGFR, Suitable for various cancers, Ready-to-use solution
Ingredients Nimotuzumab, Water for injection, Excipients
Application
Click to View more

Request to Call Back Send Inquiry

Product Details
Product Description

Biomab Injection Price And Quantity

Molecular Weight ~150 kDa
Safety Precautions Administer under medical supervision; monitor for infusion reactions.
Target Epidermal Growth Factor Receptor (EGFR)
Diluent Required No, already formulated for direct intravenous use.
Prescription Status Prescription-only medication
Marketed By Biocon Biologics Ltd.
Route of Administration Intravenous infusion
Pack Size Single-use vial, 4 ml/vial (50 mg/4 ml)

Biomab Injection Product Specifications

Temperature Needed For Fermentation Not applicable (biotechnological production, not enzyme fermentation)
Feature Humanized monoclonal antibody, Highly selective anti-EGFR, Suitable for various cancers, Ready-to-use solution
Ingredients Nimotuzumab, Water for injection, Excipients
Indication Head and neck cancer, Glioma, Non-small cell lung cancer, Esophageal cancer, Breast cancer
Enzymatic Activity Not applicable (monoclonal antibody does not have enzymatic activity)
Enzyme Types Monoclonal antibody (IgG1 class)
Salt Composition Nimotuzumab (50mg) per vial
Ph Level pH 6.0 7.0 (approx.)
Physical Color/Texture Clear to slightly opalescent, colorless solution
Fermentation Smell Odorless
Shelf Life 24 months from date of manufacture
Dosage Form Injection
Storage Instructions Store at 2C 8C, do not freeze

Molecular Weight ~150 kDa
Safety Precautions Administer under medical supervision; monitor for infusion reactions.
Target Epidermal Growth Factor Receptor (EGFR)
Diluent Required No, already formulated for direct intravenous use.
Prescription Status Prescription-only medication
Marketed By Biocon Biologics Ltd.
Route of Administration Intravenous infusion
Pack Size Single-use vial, 4 ml/vial (50 mg/4 ml)

Biomab Injection Trade Information

Main Export Market(s) Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Product Description

With an aim to establish ourselves among the leading organizations, we are engaged in offering Biomab Injection. It is used in combination with chemo therapy and radiation therapy for the treatment of squamous cell cancer of head and neck. The drug is highly demanded in hospitals and cancer institutes. It binds to the epidermal growth factor receptor and aids in treating cancer. We offer Biomab Injection at market leading prices to clients.

Features:

Effective antineoplastic agent
Inhibits the growth of cancer cells
Low indication of side effects

Targeted Immunotherapy for Multiple Cancers

Biomab Injection leverages Nimotuzumab, a humanized monoclonal antibody specifically designed to inhibit EGFR, a key protein involved in cancer cell proliferation. This therapy provides targeted immune intervention for various cancers, including head and neck, glioma, breast, non-small cell lung, and esophageal cancers, offering a versatile option for oncologists.

Ready-to-Use and Easy Administration

This intravenous infusion comes pre-formulated and ready for direct administration, removing the need for additional diluents or mixing steps. The clear, colorless solution simplifies the treatment process, helping ensure dosing accuracy and reducing preparation time for healthcare providers.

Safety First: Administration and Storage Guidelines

Biomab Injection must be administered strictly under medical supervision due to the potential for infusion reactions. Proper storage between 2C8C, and protection from freezing, is essential to maintain the efficacy and safety of the medication. Monitoring during infusion is recommended to promptly manage any adverse events.

FAQs of Biomab Injection:

Q: How is Biomab Injection administered to patients?

A: Biomab Injection is given through intravenous infusion by a qualified healthcare professional, typically within a hospital or specialized clinic setting. No additional diluent is needed as the solution is ready to use straight from the vial.

Q: What types of cancer can Biomab Injection be used to treat?

A: This medication is indicated for the treatment of head and neck cancer, glioma, non-small cell lung cancer, esophageal cancer, and breast cancer, as part of immunotherapy regimens targeting EGFR.

Q: When should Biomab Injection be given during cancer therapy?

A: The timing and frequency depend on the specific treatment protocol prescribed by your oncologist. Administration schedules are tailored to the type and stage of cancer and may be in conjunction with other therapies.

Q: Where should Biomab Injection be stored?

A: Store Biomab Injection in a refrigerator at 2C8C. It should never be frozen and must be kept away from light and out of reach of children.

Q: What safety precautions should be followed when using Biomab Injection?

A: It must only be administered by medical professionals, with careful monitoring during infusion for any signs of hypersensitivity or infusion reactions. Immediate medical intervention may be needed if reactions occur.

Q: Does Biomab Injection require any preparation before use?

A: No special preparation is necessary. Each vial is pre-formulated and ready for intravenous use, eliminating the need for dilution or reconstitution.

Q: What are the main benefits of using Biomab Injection for cancer treatment?

A: Biomab Injection offers selective EGFR inhibition, helping to slow cancer cell growth while providing a targeted immunotherapeutic approach. Its ready-to-use formulation aids safety and convenience during administration.

Tell us about your requirement

Price:

Quantity

Select Unit

50
100
200
250
500
1000+

Additional detail

Mobile number

Other Products in 'Anti Cancer Injections' category

Bleomycin Injection Salt Composition : Bleomycin Sulfate Shelf Life : 24 months from date of manufacture Dosage Form : Injection Physical Color/Texture : Other , White to offwhite lyophilized powder Ingredients : Other , Bleomycin Sulfate, Sterile Water for Injection Feature : Other, High purity, sterile, singleuse vial Indication : Used in the treatment of various cancers including Hodgkins lymphoma, nonHodgkins lymphoma, testicular cancer, and ovarian cancer. Storage Instructions : Store below 25C, protect from light, do not freeze. Fermentation Smell : Other, Odorless Application : Other, Medical use for anticancer therapy Ph Level : Neutral (approximately pH 5.0 6.0) Enzyme Types : Other, Antineoplastic glycopeptide antibiotic Enzymatic Activity : Interferes with DNA synthesis in cancer cells

Send Inquiry

Dacarbazine Injection Salt Composition : Dacarbazine Shelf Life : 36 months Dosage Form : Injection Physical Color/Texture : Other , White to offwhite lyophilized powder Ingredients : Other , Dacarbazine, excipients, sterile water for injection Feature : Other, Sterile, singleuse vial Indication : Antineoplastic agent used in the treatment of melanoma and Hodgkins lymphoma Storage Instructions : Store below 25C, protect from light Fermentation Smell : Other, Odorless Application : Other, Cancer chemotherapy Ph Level : 3.0 4.0 Enzymatic Activity : No enzymatic activity

Send Inquiry

5-fluorouracil Injection Salt Composition : 5Fluorouracil 500 mg / 10 ml Shelf Life : 24 months Dosage Form : Injection Physical Color/Texture : Other , Colorless to slightly yellow, clear, aqueous solution Ingredients : Other , Active ingredient: 5Fluorouracil; Excipients: Water for Injection, Sodium Hydroxide (for pH adjustment) Feature : Other, Sterile, preservativefree, readytouse injectable cytotoxic solution Indication : Antineoplastic agent used in the treatment of cancer, particularly colorectal, breast, stomach, and pancreatic cancers Storage Instructions : Store below 25C. Protect from light. Do not freeze. Application : Other, Intravenous administration in oncology protocols Ph Level : 8.6 9.0 Enzyme Types : Other, Not applicable (Chemotherapeutic/Antimetabolite)

Send Inquiry

Leucovorin Calcium Injection Salt Composition : Leucovorin Calcium Shelf Life : 24 months Dosage Form : Injection Physical Color/Texture : Other , Clear, colorless liquid Ingredients : Other , Leucovorin Calcium, Water for Injection, stabilizers Feature : Other, Sterile, readytouse, pyrogenfree Indication : Rescue agent after highdose methotrexate therapy, reduction of toxic effects of methotrexate Storage Instructions : Store below 25C, protect from light Fermentation Smell : Other, Odorless Application : Other, Medical, Oncology, Chemotherapy adjunct Ph Level : Neutral (approximately pH 7.5)

Send Inquiry

SEND INQUIRY CALL ME FREE